Regulation of biosynthesis of secondary metabolites. IX. The biosynthetic activity of blocked mutants of Streptomyces aureofaciens
Language English Country United States Media print
Document type Journal Article
PubMed
5785594
DOI
10.1007/bf02872782
Knihovny.cz E-resources
- MeSH
- Chlortetracycline biosynthesis MeSH
- Chromatography MeSH
- Fluorescence MeSH
- Mutation * MeSH
- Mutagens pharmacology MeSH
- Streptomyces growth & development metabolism MeSH
- Tetracycline biosynthesis MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Chlortetracycline MeSH
- Mutagens MeSH
- Tetracycline MeSH
See more in PubMed
Mutat Res. 1969 Jan-Feb;7(1):19-24 PubMed
Antimicrob Agents Chemother (Bethesda). 1965;5:982-91 PubMed
J Chromatogr. 1963 May;11:62-5 PubMed
J Gen Microbiol. 1956 Dec;15(3):599-608 PubMed
Antibiotiki (Mosc). 1958 Mar-Apr;3(2):18-21 PubMed
J Gen Microbiol. 1965 Jun;39(3):305-9 PubMed
J Hyg Epidemiol Microbiol Immunol. 1958;2(1):111-5 PubMed
J Am Pharm Assoc Am Pharm Assoc. 1949 Aug;38(8):473-5 PubMed
Proc Natl Acad Sci U S A. 1967 Sep;58(3):923-30 PubMed
Biochem Biophys Res Commun. 1965 Feb 3;18:325-31 PubMed
Experientia. 1964 Feb 15;20(2):83-4 PubMed
Can J Microbiol. 1967 Apr;13(4):389-95 PubMed
Alizarin glucosyl transferase activity in Streptomyces aureofaciens mutants
Microbial transformation of semisynthetic derivatives of daunomycinone modified in ring A
Microbial glucosidation of 1,2,4-trihydroxy-9,10-anthraquinone (purpurin)
Partial purification and properties of glucosyltransferase from Streptomyces aureofaciens
Isolation of glucosyltransferase from Streptomyces aureofaciens
Microbial glucosidation of dihydroxyanthraquinones. General properties of the glucosidation system
How many genes are required for the synthesis of chlortetracycline?